跳至主要内容
临床试验/EUCTR2006-004296-35-GB
EUCTR2006-004296-35-GB进行中(未招募)1 期

An investigation into the modulation of obesity associated monocyte/macrophage function, vascular inflammation and insulin resistance by PPAR agonist treatment

The Royal Group of Hospitals, Belfast Health and Social Care Trust0 个研究点目标入组 80 人开始时间: 2007年9月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Controls: male, 35-65 years, BMI 20-25 Kg/M2
  • Cases: male, 35-65 years, BMI > 30 Kg/M2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • cigarette smoking, clinical cardiac disease, plasma cholesterol > 7 mmol/l, fasting
  • triglycerides > 5mmol/l, blood pressure > 160/90 mmHg, diabetes/family history of diabetes, glucose intolerance or use of hypertensive; cardiac; vitamin; non-steroidal anti-inflammatory drugs or lipid-lowering therapy

研究者

发起方
The Royal Group of Hospitals, Belfast Health and Social Care Trust

相似试验